company background image
1796

GeneFerm Biotechnology TPEX:1796 Stock Report

Last Price

NT$58.20

Market Cap

NT$2.4b

7D

3.2%

1Y

74.3%

Updated

24 Sep, 2022

Data

Company Financials
1796 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends0/6

1796 Stock Overview

GeneFerm Biotechnology Co., Ltd. develops, manufactures, markets, and sells fermented health care products in Taiwan and internationally.

GeneFerm Biotechnology Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GeneFerm Biotechnology
Historical stock prices
Current Share PriceNT$58.20
52 Week HighNT$64.10
52 Week LowNT$32.85
Beta1
1 Month Change16.75%
3 Month Change44.42%
1 Year Change74.25%
3 Year Change63.48%
5 Year Change16.40%
Change since IPO-35.63%

Recent News & Updates

Shareholder Returns

1796TW Personal ProductsTW Market
7D3.2%-3.0%-3.1%
1Y74.3%-1.0%-17.6%

Return vs Industry: 1796 exceeded the TW Personal Products industry which returned -1% over the past year.

Return vs Market: 1796 exceeded the TW Market which returned -17.6% over the past year.

Price Volatility

Is 1796's price volatile compared to industry and market?
1796 volatility
1796 Average Weekly Movement5.8%
Personal Products Industry Average Movement5.6%
Market Average Movement5.0%
10% most volatile stocks in TW Market8.2%
10% least volatile stocks in TW Market2.4%

Stable Share Price: 1796 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 1796's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1988n/an/ahttps://www.geneferm.com

GeneFerm Biotechnology Co., Ltd. develops, manufactures, markets, and sells fermented health care products in Taiwan and internationally. The company offers microbial fermentation products, which includes nattokinase, red yeast rice, vitamin K2, lactic acid bacteria, etc.; and edible and medicinal mushroom fermentation, functional herbal products, fruit and vegetable fermentation concentrates, and protein products and private label supplements. It also provides microbial fermentation toll manufacturing and technical consulting services.

GeneFerm Biotechnology Co., Ltd. Fundamentals Summary

How do GeneFerm Biotechnology's earnings and revenue compare to its market cap?
1796 fundamental statistics
Market CapNT$2.41b
Earnings (TTM)NT$86.20m
Revenue (TTM)NT$585.15m

28.0x

P/E Ratio

4.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
1796 income statement (TTM)
RevenueNT$585.15m
Cost of RevenueNT$366.71m
Gross ProfitNT$218.44m
Other ExpensesNT$132.24m
EarningsNT$86.20m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)2.08
Gross Margin37.33%
Net Profit Margin14.73%
Debt/Equity Ratio5.8%

How did 1796 perform over the long term?

See historical performance and comparison

Dividends

0.1%

Current Dividend Yield

4%

Payout Ratio